HomeQLGN • NASDAQ
add
Qualigen Therapeutics Inc
Previous close
$0.30
Day range
$0.29 - $0.32
Year range
$0.28 - $1.26
Market cap
1.81M USD
Avg Volume
76.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.26M | -29.08% |
Net income | -2.45M | 61.55% |
Net profit margin | — | — |
Earnings per share | -0.15 | 66.73% |
EBITDA | -2.27M | 33.80% |
Effective tax rate | 0.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 401.80K | -87.31% |
Total assets | 2.03M | -89.35% |
Total liabilities | 4.14M | -59.90% |
Total equity | -2.10M | — |
Shares outstanding | 6.31M | — |
Price to book | -0.78 | — |
Return on assets | -179.07% | — |
Return on capital | 704.98% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.45M | 61.55% |
Cash from operations | -5.67M | -153.45% |
Cash from investing | 235.40K | 196.33% |
Cash from financing | -110.00K | -103.79% |
Net change in cash | -5.55M | -1,432.07% |
Free cash flow | -2.95M | -2,250.53% |
About
Founded
1996
Headquarters
Website
Employees
4